I never get tired of hearing more information on this research.
A synthetic genetic circuit programmed into an attenuated Salmonella enterica subspecies can be used to systemically deliver an anti-tumor toxin into mice with cancer. The circuit allows the bacterial cells inside a tumor to synchronously self-destruct by lysis, releasing the toxin directly in the tumor.
Researchers at the University of California San Diego and the Massachusetts Institute of Technology (MIT) have come up with a strategy for using synthetic biology in therapeutics. The approach enables continual production and release of drugs at disease sites in mice while simultaneously limiting the size, over time, of the populations of bacteria engineered to produce the drugs.
“This impressive study represents a big step towards one of the great dreams of synthetic biology: rationally programming cells, in this case bacteria, to exhibit complex, dynamic, and beneficial behaviors in a host organism,” Michael Elowitz, whose Caltech lab builds synthetic genetic circuits and who was not involved in the work, wrote in an email to The Scientist.
(Medical Xpress)—A team of researchers at Sichuan University’s West China Hospital has announced plans to begin a clinical trial where cells modified using the CRISPR gene editing technique will be used on human beings for the very first time. They plan to edit genes in such a way as to turn off a gene that encodes for a protein that has been shown by prior research to slow an immune response and by so doing treat patients with lung cancer.
The CRISPR gene editing technique has been in the news a lot of late as scientists creep ever closer to using it as a means to treat diseases or to change the very nature of biological beings. China has been a leader in promoting such research on human beings—they were the first to use the technique to on human embryos.
This new effort is seen as far less controversial—a team in the U.S. is planning a similar study as soon as they can get regulators to greenlight their project. The Chinese team plans to retrieve T cells from patients that have incurable lung cancer and then edit the genes in those cells. More specifically, they will be looking to disable a gene that encodes for a protein called PD-1—prior research has shown that it acts as a brake on an immune response to help prevent attacks on healthy cells. Once the cells have been edited and inspected very carefully to make sure there were no editing errors they will be allowed to multiply and then all of the cells will be injected back into the same patient’s bloodstream. It is hoped that the edited cells will cause the immune system to mount a more aggressive attack on tumor cells, killing them and curing the patient.
Perfecting Synthetic biology — this definitely is advancement forward in the larger Singularity story.
In both higher organisms and bacteria, DNA must be segregated when cells divide, ensuring that the requisite share of duplicated DNA goes into each new cell. While previous studies indicated that bacteria and higher organisms use quite different systems to perform this task, A*STAR researchers have now found a bacterium that uses filaments with key similarities to those in multicellular organisms, including humans.
Robert Robinson from the A*STAR Institute of Molecular and Cell Biology has a long-standing interest in what he calls the “biological machines” that move DNA around when cells divide. He and his co-workers had gleaned from gene sequencing analysis that there was something distinctive about the DNA-moving machinery in the bacterium Bacillus thuringiensis.
Along with an international team of colleagues, the A*STAR researchers used electron microscopy and biochemical analysis to investigate the way small circular strands of DNA called plasmids moved in this bacterium. They identified a novel form of bacterial filament that combines to form tubules with some similarities to the microtubules observed in higher organisms. Bacterial systems previously studied also use protein filaments to move DNA, but they do not share such obvious similarities to those of higher organisms. The new-found similarity in Bacillus thuringiensis is of great interest from an evolutionary perspective as it suggests that evolution has furnished at least some bacteria and multicellular organisms with different machineries but similar methods to manipulate DNA.
Beautiful.
Researchers at the University of California San Diego and the Massachusetts Institute of Technology (MIT) have come up with a strategy for using synthetic biology in therapeutics. The approach enables continual production and release of drugs at disease sites in mice while simultaneously limiting the size, over time, of the populations of bacteria engineered to produce the drugs. The findings are published in the July 20 online issue of Nature.
UC San Diego researchers led by Jeff Hasty, a professor of bioengineering and biology, engineered a clinically relevant bacterium to produce cancer drugs and then self-destruct and release the drugs at the site of tumors. The team then transferred the bacterial therapy to their MIT collaborators for testing in an animal model of colorectal metastasis. The design of the therapy represents a culmination of four previous Nature papers from the UC San Diego group that describe the systematic development of engineered genetic clocks and synchronization. Over the years, the researchers have employed a broad approach that spans the scales of synthetic biology.
The new study offers a therapeutic approach that minimizes damage to surrounding cells.
Why Plants? Part III – Rise of The Plant Machines by Orlando de Lange.
Everyone talks about the rise of the robots. What about the rise of the “Vegetation/ Plant Machines?”
In part 3 of our series on plant synthetic biology, Orlando de Lange (@SeaGreenODL) of The New Leaf blog introduces how synbio approaches are being used to develop novel disease resistant crops, overcoming some of the challenges faced by monoculture farming.
The King’s man
In 1970 an unassuming American man with greying hair and large spectacles stood before the King of Norway and was awarded the Nobel Peace Prize. This prize of international renown is set aside for individuals who have made the greatest possible contribution to peace among nations. Who was the king’s man in 1970? A president, a diplomat, a great writer, perhaps? No, he was crop scientist and plant breeder Norman Borlaug, founding father of the Green Revolution.
Arthritis sufferers have been offered new hope after scientists grew a ‘living hip’ in the lab which not only replaces worn cartilage but stops painful joints returning.
Researchers in the US have used stem cells to grow cartilage in the exact shape of a hip joint while also genetically engineering the tissue to release anti-inflammatory molecules to fend off the return of arthritis.
The idea is to implant the perfectly shaped cartilage around the joint to extend its life before arthritis has caused too much damage to the bone.
Biowire.
Researchers led by microbiologist Derek Lovely say the wires, which rival the thinnest wires known to man, are produced from renewable, inexpensive feedstocks and avoid the harsh chemical processes typically used to produce nanoelectronic materials.
Lovley says, “New sources of electronic materials are needed to meet the increasing demand for making smaller, more powerful electronic devices in a sustainable way.” The ability to mass-produce such thin conductive wires with this sustainable technology has many potential applications in electronic devices, functioning not only as wires, but also transistors and capacitors. Proposed applications include biocompatible sensors, computing devices, and as components of solar panels.
This advance began a decade ago, when Lovley and colleagues discovered that Geobacter, a common soil microorganism, could produce “microbial nanowires,” electrically conductive protein filaments that help the microbe grow on the iron minerals abundant in soil. These microbial nanowires were conductive enough to meet the bacterium’s needs, but their conductivity was well below the conductivities of organic wires that chemists could synthesize.
Can serve many uses such as geneology, etc. However, the bigger advancement will be with criminal/ legal investigations.
Rice University researchers have developed gas biosensors to “see” into soil and allow them to follow the behavior of the microbial communities within.
In a study in the American Chemical Society’s journal Environmental Science and Technology, the Rice team described using genetically engineered bacteria that release methyl halide gases to monitor microbial gene expression in soil samples in the lab.
The bacteria are programmed using synthetic biology to release gas to report when they exchange DNA through horizontal gene transfer, the process by which organisms share genetic traits without a parent-to-child relationship. The biosensors allow researchers to monitor such processes in real time without having to actually see into or disturb a lab soil sample.
Woo and other entrepreneurs are using fasts and other tricks to “hack” their brain chemistry like they would a computer, hoping to give themselves an edge as they strive to dream up the next billion-dollar idea. Known by insiders as “biohacking,” the push for cognitive self-improvement is gaining momentum in the Silicon Valley tech world, where workers face constant pressure to innovate and produce at the highest levels.
